Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

被引：8
|
作者：
Clark, P. J. [1 ,2 ]
Thompson, A. J. V. [1 ,2 ]
McHutchison, J. G. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
基金：
英国医学研究理事会;
关键词：
INTERFERON-LAMBDA; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; GENOTYPE-1; INHIBITOR; THERAPY; TYPE-1;
D O I：
10.1038/clpt.2010.185
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development.(1) For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers, and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
引用
收藏
页码：708 / 711
页数：4
相关论文
共 50 条
  • [41] miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection
    Shin, Jae Il
    Eisenhut, Michael
    NATURE REVIEWS IMMUNOLOGY, 2013, 13 (12) : 902 - 902
  • [42] IL28B Polymorphisms and Clinical Implications for Hepatitis C Virus Infection in Uzbekistan
    Khudayberganova, Dinara
    Sugiyama, Masaya
    Masaki, Naohiko
    Nishida, Nao
    Mukaide, Motokazu
    Sekler, Dildora
    Latipov, Renat
    Nataliya, Kan
    Dildora, Suyarkulova
    Sharapov, Said
    Usmanova, Guzal
    Raxmanov, Mahmarajab
    Musabaev, Erkin
    Mizokami, Masashi
    PLOS ONE, 2014, 9 (03):
  • [43] IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice
    George, Jacob
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 14 - 14
  • [44] IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice
    Ahlenstiel, Golo
    Booth, David R.
    George, Jacob
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (09) : 903 - 910
  • [45] IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice
    Golo Ahlenstiel
    David R. Booth
    Jacob George
    Journal of Gastroenterology, 2010, 45 : 903 - 910
  • [46] Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C
    Sugiyama, Masaya
    Tanaka, Yasuhito
    Nakanishi, Makoto
    Mizokami, Masashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 (03) : 263 - 269
  • [47] EXPLORATION OF SERUM ADIPOCYTOKINE ASSOCIATIONS WITH IL28B GENOTYPE IN CHRONIC HEPATITIS C
    Clark, P. J.
    Thompson, A. J.
    Tillmann, H. L.
    Jazwinski, A.
    Naggie, S.
    Muir, A. J.
    Patel, K.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S344 - S344
  • [48] The influence of IL28B polymorphisms on treatment response in patients with chronic hepatitis C
    Svorcan, Petar
    Lazarevic, Ivana
    Delic, Dragan
    Jovanovic, Tanja
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 206 - 206
  • [49] Role of IL28B for chronic hepatitis C treatment toward personalized medicine
    Matsuura, Kentaro
    Watanabe, Tsunamasa
    Tanaka, Yasuhito
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (02) : 241 - 249
  • [50] IL28B GENOTYPE IS NOT ASSOCIATED WITH INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS
    Degasperi, E.
    Valenti, L.
    Aghemo, A.
    De Francesco, R.
    Soffredini, R.
    D'Ambrosio, R.
    Rumi, M.
    Donnici, L.
    Cheroni, C.
    Zanoni, V.
    Orsi, E.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S183 - S183
12345